The Molecular Diagnostics program provides a free of cost, early and specific diagnosis for children and adults of all ages and genders in poverty, affected by various types of cancer, mainly leukemia and solid tumors. This type of testing improves the quality of life of patients, their prognosis and response to treatment, and increases their survival rate due to early detection, stratification of disease risk and the possibility of determining the best treatment option for the specific diagnosis.